✦ LIBER ✦

Role of Isotope Selection in Long-term Outcomes in Patients With Intermediate-risk Prostate Cancer Treated With a Combination of External Beam Radiotherapy and Low-dose-rate Interstitial Brachytherapy

✍ Scribed by A. Gabriella Wernicke; Michael Shamis; Weisi Yan; Samuel Trichter; Albert M. Sabbas; Yevgenia Goltser; Paul J. Christos; Jennifer S. Brennan; Bhupesh Parashar; Dattatreyudu Nori

Book ID: 116955213
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 260 KB
Volume: 79
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2012.01.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in cause-specific mortality

Differences in cause-specific mortality in patients with low-and intermediate-risk prostate cancer treated with brachytherapy, external beam radiotherapy, or radical prostatectomy

✍ Jay P. Ciezki; Chandana A. Reddy; Clifford Robinson; Eric A. Klein; Kenneth Ange 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A multicentric Phase II study of high-do

A multicentric Phase II study of high-dose-rate brachytherapy boost in combination with external beam radiotherapy in patients with intermediate-risk carcinoma of the prostate

✍ Tee S. Lim; Gerard C. Morton; Andrew Loblaw; Raxa Sankreacha; Eric Vigneault; Co 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 42 KB

MP-14.20: Intermediate-term outcome and

MP-14.20: Intermediate-term outcome and morbidity of high-dose-rate brachytherapy (HDR-BT) combined with external beam radiotherapy (EBRT) for clinically localized prostate cancer

✍ T. Inagaki; T. Mori 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Combination Low Dose Rate Brachytherapy

Combination Low Dose Rate Brachytherapy and External Beam Radiation Treatment in Patients with Intermediate and High Risk Prostate Cancer: Clinical Efficacy and Patient Reported Outcomes- The University of Michigan Experience

✍ E.I. Abu-Isa; M.S. Jawad; C. Evans; G. Geraghty; V. Narayana; R.J. Winfield; D.A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

167 Is 5-year survival rate a real measu

167 Is 5-year survival rate a real measure of outcome in cervix cancer patients treated by radiotherapy? Long-term results in patients treated with external beam radiation therapy and high dose rate brachytherapy

✍ L. Souhami; R. Corns; M. Duclos; G. Stanimir 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Impact of age on biochemical control in

Impact of age on biochemical control in a cohort of intermediate- and high-risk prostate cancer patients treated with high-dose-rate brachytherapy boost combined with pelvic external beam radiation therapy

✍ Amy L. Limbacher; Michel Ghilezan; Gary Gustafson; Peter Y. Chen; Christine Mitc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 80 KB